|
|||
2009-09-03 11:41:48 CEST 2009-09-03 11:43:32 CEST REGULATED INFORMATION Össur hf. - Company AnnouncementOssur's listing on NASDAQ OMX Copenhagen approvedOssur hf.'s application for listing of the Company's shares on NASDAQ OMX Copenhagen has been approved. Ossur's shares will be officially listed and admitted to trading 4 September 2009 (stock symbol OSSR, ISIN IS0000000040). Ossur's shares will continue to be listed on NASDAQ OMX Iceland. Ossur has 423,000,000 issued shares with a nominal value of one Icelandic krona. All the shares are of the same class and carry equal rights. Nordea Bank Danmark A/S is the issuing agent for Ossur's shares in respect of shares registered with VP Securities A/S in Denmark. Ossur has moreover entered into a market making agreement with Nordea Markets (Division of Nordea Bank Danmark A/S). In connection with the listing Ossur has issued a Summary document, approved by the Danish Financial Supervisory Authority, that reflects the essential characteristics and risks associated with Ossur and the Company's shares. An English version of the Summary Document is attached hereto. Further information on Ossur, including the Summary document (available in Danish and English), an introduction brochure about Ossur and its operations, and detailed information on the trading of Ossur shares and transfer between Iceland and Denmark can be found on Ossur's website: www.ossur.com/investors. Ossur contacts: Jon Sigurdsson, President & CEO, tel. +354 515 1300 Hjorleifur Palsson, CFO, tel. +354 515 1300 Sigurborg Arnarsdottir, IR Manager, tel. +354 664 1044 About Ossur Ossur (OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of bracing and supports, prosthetic limbs and compression therapies. A recognized "Technology Pioneer", Ossur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Ossur's educational programs and business solutions. Headquartered in Iceland, Ossur has major operations in America and Europe, with additional distributors worldwide. |
|||
|